perfluorooctane sulfonic acid has been researched along with Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abedi-Valugerdi, M; Bogdanska, J; Butenhoff, JL; Chang, SC; DePierre, JW; Ehresman, DJ; Nelson, BD; Qazi, MR; Xia, Z | 1 |
1 other study(ies) available for perfluorooctane sulfonic acid and Atrophy
Article | Year |
---|---|
The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARa
Topics: Alkanesulfonic Acids; Animals; Atrophy; B-Lymphocytes; Body Weight; Caprylates; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Flow Cytometry; Fluorocarbons; Immunophenotyping; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Organ Size; PPAR alpha; Spleen; T-Lymphocytes; Thymus Gland | 2009 |